Suchergebnisse - "PARP inhibitor"

PubPharm (2.849)

81

Biology and Development of DNA-Targeted Drugs, Focusing on Synthetic Lethality, DNA Repair, and Epigenetic Modifications for Cancer : A Review

enthalten in: International journal of molecular sciences | 2024

von Watanabe, K. | Seki, N.

82

ER-positive and BRCA2-mutated breast cancer: a literature review

enthalten in: European journal of medical research | 2024

von Li, P. | Zhu, Y. | Cao, W. | +1

83

Targeting NEAT1 Affects the Sensitivity to PARPi in Serous Ovarian Cancer by Regulating the Homologous Recombination Repair Pathway

enthalten in: Journal of Cancer | 2024

von Liu, Y. | Liu, G.

84

Radiosensitization of Osteosarcoma Cells Using the PARP Inhibitor Olaparib Combined with X-rays or Carbon Ions

enthalten in: Journal of Cancer | 2024

von Dong, M. | Luo, H. | Liu, R. | +8

85

Targeting BRCA and PALB2 in Pancreatic Cancer

enthalten in: Current treatment options in oncology | 2024

von Anbil, S. | Reiss, K.

86

PARP Inhibitors in Breast Cancer: a Short Communication

enthalten in: Current oncology reports | 2024

von Daly, G. | AlRawashdeh, M. | McGrath, J. | +6

87

Co-Packaged PARP inhibitor and photosensitizer for targeted photo-chemotherapy of 3D ovarian cancer spheroids

in: Cell & Bioscience | 2024

von Aaron Sorrin | Anika Dasgupta | Kathryn McNaughton | +5

88

Cardioprotective Effects of PARP Inhibitors: A Re-Analysis of a Meta-Analysis and a Real-Word Data Analysis Using the FAERS Database

in: Journal of Clinical Medicine | 2024

von Ja-Young Han | Young-Eun Seo | Jae-Hee Kwon | +2

89

PARP Inhibitors in the Treatment of Prostate Cancer: From Scientific Rationale to Clinical Development

in: The World Journal of Men's Health | 2024

von Whi-An Kwon

90

Natural pentacyclic triterpenoid from Pristimerin sensitizes p53-deficient tumor to PARP inhibitor by ubiquitination of Chk1

in: Pharmacological Research | 2024

von Li Tao | Xiangyu Xia | Shujing Kong | +3